Global Glycopyrrolate Injection Market Research Report 2024

Report ID: 1800425 | Published Date: Jan 2025 | No. of Page: 113 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
1 Glycopyrrolate Injection Market Overview
    1.1 Product Overview and Scope of Glycopyrrolate Injection
    1.2 Glycopyrrolate Injection Segment by Type
        1.2.1 Global Glycopyrrolate Injection Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 0.2mg/ml
        1.2.3 0.4mg/2ml
        1.2.4 1mg/5ml
        1.2.5 4mg/20ml
    1.3 Glycopyrrolate Injection Segment by Application
        1.3.1 Global Glycopyrrolate Injection Sales Comparison by Application: (2022-2028)
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 Global Glycopyrrolate Injection Market Size Estimates and Forecasts
        1.4.1 Global Glycopyrrolate Injection Revenue 2017-2028
        1.4.2 Global Glycopyrrolate Injection Sales 2017-2028
        1.4.3 Glycopyrrolate Injection Market Size by Region: 2017 Versus 2021 Versus 2028
2 Glycopyrrolate Injection Market Competition by Manufacturers
    2.1 Global Glycopyrrolate Injection Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Glycopyrrolate Injection Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Glycopyrrolate Injection Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Glycopyrrolate Injection Manufacturing Sites, Area Served, Product Type
    2.5 Glycopyrrolate Injection Market Competitive Situation and Trends
        2.5.1 Glycopyrrolate Injection Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Glycopyrrolate Injection Players Market Share by Revenue
        2.5.3 Global Glycopyrrolate Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Glycopyrrolate Injection Retrospective Market Scenario by Region
    3.1 Global Glycopyrrolate Injection Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Glycopyrrolate Injection Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Glycopyrrolate Injection Market Facts & Figures by Country
        3.3.1 North America Glycopyrrolate Injection Sales by Country
        3.3.2 North America Glycopyrrolate Injection Revenue by Country
        3.3.3 United States
        3.3.4 Canada
    3.4 Europe Glycopyrrolate Injection Market Facts & Figures by Country
        3.4.1 Europe Glycopyrrolate Injection Sales by Country
        3.4.2 Europe Glycopyrrolate Injection Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Glycopyrrolate Injection Market Facts & Figures by Region
        3.5.1 Asia Pacific Glycopyrrolate Injection Sales by Region
        3.5.2 Asia Pacific Glycopyrrolate Injection Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 China Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
    3.6 Latin America Glycopyrrolate Injection Market Facts & Figures by Country
        3.6.1 Latin America Glycopyrrolate Injection Sales by Country
        3.6.2 Latin America Glycopyrrolate Injection Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
        3.6.6 Colombia
    3.7 Middle East and Africa Glycopyrrolate Injection Market Facts & Figures by Country
        3.7.1 Middle East and Africa Glycopyrrolate Injection Sales by Country
        3.7.2 Middle East and Africa Glycopyrrolate Injection Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Glycopyrrolate Injection Historic Market Analysis by Type
    4.1 Global Glycopyrrolate Injection Sales Market Share by Type (2017-2022)
    4.2 Global Glycopyrrolate Injection Revenue Market Share by Type (2017-2022)
    4.3 Global Glycopyrrolate Injection Price by Type (2017-2022)
5 Global Glycopyrrolate Injection Historic Market Analysis by Application
    5.1 Global Glycopyrrolate Injection Sales Market Share by Application (2017-2022)
    5.2 Global Glycopyrrolate Injection Revenue Market Share by Application (2017-2022)
    5.3 Global Glycopyrrolate Injection Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Accord Healthcare
        6.1.1 Accord Healthcare Corporation Information
        6.1.2 Accord Healthcare Description and Business Overview
        6.1.3 Accord Healthcare Glycopyrrolate Injection Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Accord Healthcare Glycopyrrolate Injection Product Portfolio
        6.1.5 Accord Healthcare Recent Developments/Updates
    6.2 Advanz Pharma
        6.2.1 Advanz Pharma Corporation Information
        6.2.2 Advanz Pharma Description and Business Overview
        6.2.3 Advanz Pharma Glycopyrrolate Injection Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Advanz Pharma Glycopyrrolate Injection Product Portfolio
        6.2.5 Advanz Pharma Recent Developments/Updates
    6.3 American Regent
        6.3.1 American Regent Corporation Information
        6.3.2 American Regent Description and Business Overview
        6.3.3 American Regent Glycopyrrolate Injection Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 American Regent Glycopyrrolate Injection Product Portfolio
        6.3.5 American Regent Recent Developments/Updates
    6.4 Amneal Pharmaceuticals
        6.4.1 Amneal Pharmaceuticals Corporation Information
        6.4.2 Amneal Pharmaceuticals Description and Business Overview
        6.4.3 Amneal Pharmaceuticals Glycopyrrolate Injection Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Amneal Pharmaceuticals Glycopyrrolate Injection Product Portfolio
        6.4.5 Amneal Pharmaceuticals Recent Developments/Updates
    6.5 Apotex
        6.5.1 Apotex Corporation Information
        6.5.2 Apotex Description and Business Overview
        6.5.3 Apotex Glycopyrrolate Injection Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 Apotex Glycopyrrolate Injection Product Portfolio
        6.5.5 Apotex Recent Developments/Updates
    6.6 BE Pharmaceuticals
        6.6.1 BE Pharmaceuticals Corporation Information
        6.6.2 BE Pharmaceuticals Description and Business Overview
        6.6.3 BE Pharmaceuticals Glycopyrrolate Injection Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 BE Pharmaceuticals Glycopyrrolate Injection Product Portfolio
        6.6.5 BE Pharmaceuticals Recent Developments/Updates
    6.7 BluePoint Laboratories
        6.6.1 BluePoint Laboratories Corporation Information
        6.6.2 BluePoint Laboratories Description and Business Overview
        6.6.3 BluePoint Laboratories Glycopyrrolate Injection Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 BluePoint Laboratories Glycopyrrolate Injection Product Portfolio
        6.7.5 BluePoint Laboratories Recent Developments/Updates
    6.8 Caplin Steriles
        6.8.1 Caplin Steriles Corporation Information
        6.8.2 Caplin Steriles Description and Business Overview
        6.8.3 Caplin Steriles Glycopyrrolate Injection Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 Caplin Steriles Glycopyrrolate Injection Product Portfolio
        6.8.5 Caplin Steriles Recent Developments/Updates
    6.9 Civica
        6.9.1 Civica Corporation Information
        6.9.2 Civica Description and Business Overview
        6.9.3 Civica Glycopyrrolate Injection Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 Civica Glycopyrrolate Injection Product Portfolio
        6.9.5 Civica Recent Developments/Updates
    6.10 Fresenius Kabi
        6.10.1 Fresenius Kabi Corporation Information
        6.10.2 Fresenius Kabi Description and Business Overview
        6.10.3 Fresenius Kabi Glycopyrrolate Injection Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 Fresenius Kabi Glycopyrrolate Injection Product Portfolio
        6.10.5 Fresenius Kabi Recent Developments/Updates
    6.11 Gland Pharma
        6.11.1 Gland Pharma Corporation Information
        6.11.2 Gland Pharma Glycopyrrolate Injection Description and Business Overview
        6.11.3 Gland Pharma Glycopyrrolate Injection Sales, Revenue and Gross Margin (2017-2022)
        6.11.4 Gland Pharma Glycopyrrolate Injection Product Portfolio
        6.11.5 Gland Pharma Recent Developments/Updates
    6.12 Hikma
        6.12.1 Hikma Corporation Information
        6.12.2 Hikma Glycopyrrolate Injection Description and Business Overview
        6.12.3 Hikma Glycopyrrolate Injection Sales, Revenue and Gross Margin (2017-2022)
        6.12.4 Hikma Glycopyrrolate Injection Product Portfolio
        6.12.5 Hikma Recent Developments/Updates
    6.13 Khandelwal Laboratories
        6.13.1 Khandelwal Laboratories Corporation Information
        6.13.2 Khandelwal Laboratories Glycopyrrolate Injection Description and Business Overview
        6.13.3 Khandelwal Laboratories Glycopyrrolate Injection Sales, Revenue and Gross Margin (2017-2022)
        6.13.4 Khandelwal Laboratories Glycopyrrolate Injection Product Portfolio
        6.13.5 Khandelwal Laboratories Recent Developments/Updates
    6.14 Meitheal
        6.14.1 Meitheal Corporation Information
        6.14.2 Meitheal Glycopyrrolate Injection Description and Business Overview
        6.14.3 Meitheal Glycopyrrolate Injection Sales, Revenue and Gross Margin (2017-2022)
        6.14.4 Meitheal Glycopyrrolate Injection Product Portfolio
        6.14.5 Meitheal Recent Developments/Updates
    6.15 Nivagen Pharmaceuticals
        6.15.1 Nivagen Pharmaceuticals Corporation Information
        6.15.2 Nivagen Pharmaceuticals Glycopyrrolate Injection Description and Business Overview
        6.15.3 Nivagen Pharmaceuticals Glycopyrrolate Injection Sales, Revenue and Gross Margin (2017-2022)
        6.15.4 Nivagen Pharmaceuticals Glycopyrrolate Injection Product Portfolio
        6.15.5 Nivagen Pharmaceuticals Recent Developments/Updates
    6.16 NorthStar Rx
        6.16.1 NorthStar Rx Corporation Information
        6.16.2 NorthStar Rx Glycopyrrolate Injection Description and Business Overview
        6.16.3 NorthStar Rx Glycopyrrolate Injection Sales, Revenue and Gross Margin (2017-2022)
        6.16.4 NorthStar Rx Glycopyrrolate Injection Product Portfolio
        6.16.5 NorthStar Rx Recent Developments/Updates
    6.17 Sandoz
        6.17.1 Sandoz Corporation Information
        6.17.2 Sandoz Glycopyrrolate Injection Description and Business Overview
        6.17.3 Sandoz Glycopyrrolate Injection Sales, Revenue and Gross Margin (2017-2022)
        6.17.4 Sandoz Glycopyrrolate Injection Product Portfolio
        6.17.5 Sandoz Recent Developments/Updates
    6.18 Solco Healthcare
        6.18.1 Solco Healthcare Corporation Information
        6.18.2 Solco Healthcare Glycopyrrolate Injection Description and Business Overview
        6.18.3 Solco Healthcare Glycopyrrolate Injection Sales, Revenue and Gross Margin (2017-2022)
        6.18.4 Solco Healthcare Glycopyrrolate Injection Product Portfolio
        6.18.5 Solco Healthcare Recent Developments/Updates
    6.19 SteriMax
        6.19.1 SteriMax Corporation Information
        6.19.2 SteriMax Glycopyrrolate Injection Description and Business Overview
        6.19.3 SteriMax Glycopyrrolate Injection Sales, Revenue and Gross Margin (2017-2022)
        6.19.4 SteriMax Glycopyrrolate Injection Product Portfolio
        6.19.5 SteriMax Recent Developments/Updates
    6.20 Xiromed
        6.20.1 Xiromed Corporation Information
        6.20.2 Xiromed Glycopyrrolate Injection Description and Business Overview
        6.20.3 Xiromed Glycopyrrolate Injection Sales, Revenue and Gross Margin (2017-2022)
        6.20.4 Xiromed Glycopyrrolate Injection Product Portfolio
        6.20.5 Xiromed Recent Developments/Updates
    6.21 AuroMedics Pharma
        6.21.1 AuroMedics Pharma Corporation Information
        6.21.2 AuroMedics Pharma Glycopyrrolate Injection Description and Business Overview
        6.21.3 AuroMedics Pharma Glycopyrrolate Injection Sales, Revenue and Gross Margin (2017-2022)
        6.21.4 AuroMedics Pharma Glycopyrrolate Injection Product Portfolio
        6.21.5 AuroMedics Pharma Recent Developments/Updates
    6.22 Par Pharmaceutical
        6.22.1 Par Pharmaceutical Corporation Information
        6.22.2 Par Pharmaceutical Glycopyrrolate Injection Description and Business Overview
        6.22.3 Par Pharmaceutical Glycopyrrolate Injection Sales, Revenue and Gross Margin (2017-2022)
        6.22.4 Par Pharmaceutical Glycopyrrolate Injection Product Portfolio
        6.22.5 Par Pharmaceutical Recent Developments/Updates
    6.23 Piramal Critical Care
        6.23.1 Piramal Critical Care Corporation Information
        6.23.2 Piramal Critical Care Glycopyrrolate Injection Description and Business Overview
        6.23.3 Piramal Critical Care Glycopyrrolate Injection Sales, Revenue and Gross Margin (2017-2022)
        6.23.4 Piramal Critical Care Glycopyrrolate Injection Product Portfolio
        6.23.5 Piramal Critical Care Recent Developments/Updates
    6.24 Somerset Therapeutics
        6.24.1 Somerset Therapeutics Corporation Information
        6.24.2 Somerset Therapeutics Glycopyrrolate Injection Description and Business Overview
        6.24.3 Somerset Therapeutics Glycopyrrolate Injection Sales, Revenue and Gross Margin (2017-2022)
        6.24.4 Somerset Therapeutics Glycopyrrolate Injection Product Portfolio
        6.24.5 Somerset Therapeutics Recent Developments/Updates
    6.25 West-ward Pharmaceutical
        6.25.1 West-ward Pharmaceutical Corporation Information
        6.25.2 West-ward Pharmaceutical Glycopyrrolate Injection Description and Business Overview
        6.25.3 West-ward Pharmaceutical Glycopyrrolate Injection Sales, Revenue and Gross Margin (2017-2022)
        6.25.4 West-ward Pharmaceutical Glycopyrrolate Injection Product Portfolio
        6.25.5 West-ward Pharmaceutical Recent Developments/Updates
    6.26 Zydus Pharmaceuticals
        6.26.1 Zydus Pharmaceuticals Corporation Information
        6.26.2 Zydus Pharmaceuticals Glycopyrrolate Injection Description and Business Overview
        6.26.3 Zydus Pharmaceuticals Glycopyrrolate Injection Sales, Revenue and Gross Margin (2017-2022)
        6.26.4 Zydus Pharmaceuticals Glycopyrrolate Injection Product Portfolio
        6.26.5 Zydus Pharmaceuticals Recent Developments/Updates
    6.27 Hengrui Pharmaceuticals
        6.27.1 Hengrui Pharmaceuticals Corporation Information
        6.27.2 Hengrui Pharmaceuticals Glycopyrrolate Injection Description and Business Overview
        6.27.3 Hengrui Pharmaceuticals Glycopyrrolate Injection Sales, Revenue and Gross Margin (2017-2022)
        6.27.4 Hengrui Pharmaceuticals Glycopyrrolate Injection Product Portfolio
        6.27.5 Hengrui Pharmaceuticals Recent Developments/Updates
    6.28 Jiabo Pharmaceutical
        6.28.1 Jiabo Pharmaceutical Corporation Information
        6.28.2 Jiabo Pharmaceutical Glycopyrrolate Injection Description and Business Overview
        6.28.3 Jiabo Pharmaceutical Glycopyrrolate Injection Sales, Revenue and Gross Margin (2017-2022)
        6.28.4 Jiabo Pharmaceutical Glycopyrrolate Injection Product Portfolio
        6.28.5 Jiabo Pharmaceutical Recent Developments/Updates
    6.29 Easton Biopharmaceuticals
        6.29.1 Easton Biopharmaceuticals Corporation Information
        6.29.2 Easton Biopharmaceuticals Glycopyrrolate Injection Description and Business Overview
        6.29.3 Easton Biopharmaceuticals Glycopyrrolate Injection Sales, Revenue and Gross Margin (2017-2022)
        6.29.4 Easton Biopharmaceuticals Glycopyrrolate Injection Product Portfolio
        6.29.5 Easton Biopharmaceuticals Recent Developments/Updates
7 Glycopyrrolate Injection Manufacturing Cost Analysis
    7.1 Glycopyrrolate Injection Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Glycopyrrolate Injection
    7.4 Glycopyrrolate Injection Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Glycopyrrolate Injection Distributors List
    8.3 Glycopyrrolate Injection Customers
9 Glycopyrrolate Injection Market Dynamics
    9.1 Glycopyrrolate Injection Industry Trends
    9.2 Glycopyrrolate Injection Market Drivers
    9.3 Glycopyrrolate Injection Market Challenges
    9.4 Glycopyrrolate Injection Market Restraints
10 Global Market Forecast
    10.1 Glycopyrrolate Injection Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Glycopyrrolate Injection by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Glycopyrrolate Injection by Type (2023-2028)
    10.2 Glycopyrrolate Injection Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Glycopyrrolate Injection by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Glycopyrrolate Injection by Application (2023-2028)
    10.3 Glycopyrrolate Injection Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Glycopyrrolate Injection by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Glycopyrrolate Injection by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer
List of Tables
    Table 1. Global Glycopyrrolate Injection Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Glycopyrrolate Injection Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Glycopyrrolate Injection Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Glycopyrrolate Injection Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Glycopyrrolate Injection Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Glycopyrrolate Injection Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Glycopyrrolate Injection Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Glycopyrrolate Injection Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Glycopyrrolate Injection Average Price (US$/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Glycopyrrolate Injection Manufacturing Sites and Area Served
    Table 11. Manufacturers Glycopyrrolate Injection Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Glycopyrrolate Injection by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glycopyrrolate Injection as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Glycopyrrolate Injection Sales by Region (2017-2022) & (K Units)
    Table 16. Global Glycopyrrolate Injection Sales Market Share by Region (2017-2022)
    Table 17. Global Glycopyrrolate Injection Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Glycopyrrolate Injection Revenue Market Share by Region (2017-2022)
    Table 19. North America Glycopyrrolate Injection Sales by Country (2017-2022) & (K Units)
    Table 20. North America Glycopyrrolate Injection Sales Market Share by Country (2017-2022)
    Table 21. North America Glycopyrrolate Injection Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Glycopyrrolate Injection Revenue Market Share by Country (2017-2022)
    Table 23. Europe Glycopyrrolate Injection Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Glycopyrrolate Injection Sales Market Share by Country (2017-2022)
    Table 25. Europe Glycopyrrolate Injection Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Glycopyrrolate Injection Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Glycopyrrolate Injection Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Glycopyrrolate Injection Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Glycopyrrolate Injection Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Glycopyrrolate Injection Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Glycopyrrolate Injection Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Glycopyrrolate Injection Sales Market Share by Country (2017-2022)
    Table 33. Latin America Glycopyrrolate Injection Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Glycopyrrolate Injection Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Glycopyrrolate Injection Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Glycopyrrolate Injection Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Glycopyrrolate Injection Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Glycopyrrolate Injection Revenue Market Share by Country (2017-2022)
    Table 39. Global Glycopyrrolate Injection Sales by Type (2017-2022) & (K Units)
    Table 40. Global Glycopyrrolate Injection Sales Market Share by Type (2017-2022)
    Table 41. Global Glycopyrrolate Injection Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Glycopyrrolate Injection Revenue Share by Type (2017-2022)
    Table 43. Global Glycopyrrolate Injection Price by Type (2017-2022) & (US$/Unit)
    Table 44. Global Glycopyrrolate Injection Sales (K Units) by Application (2017-2022)
    Table 45. Global Glycopyrrolate Injection Sales Market Share by Application (2017-2022)
    Table 46. Global Glycopyrrolate Injection Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Glycopyrrolate Injection Revenue Share by Application (2017-2022)
    Table 48. Global Glycopyrrolate Injection Price by Application (2017-2022) & (US$/Unit)
    Table 49. Accord Healthcare Corporation Information
    Table 50. Accord Healthcare Description and Business Overview
    Table 51. Accord Healthcare Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 52. Accord Healthcare Glycopyrrolate Injection Product
    Table 53. Accord Healthcare Recent Developments/Updates
    Table 54. Advanz Pharma Corporation Information
    Table 55. Advanz Pharma Description and Business Overview
    Table 56. Advanz Pharma Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 57. Advanz Pharma Glycopyrrolate Injection Product
    Table 58. Advanz Pharma Recent Developments/Updates
    Table 59. American Regent Corporation Information
    Table 60. American Regent Description and Business Overview
    Table 61. American Regent Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 62. American Regent Glycopyrrolate Injection Product
    Table 63. American Regent Recent Developments/Updates
    Table 64. Amneal Pharmaceuticals Corporation Information
    Table 65. Amneal Pharmaceuticals Description and Business Overview
    Table 66. Amneal Pharmaceuticals Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 67. Amneal Pharmaceuticals Glycopyrrolate Injection Product
    Table 68. Amneal Pharmaceuticals Recent Developments/Updates
    Table 69. Apotex Corporation Information
    Table 70. Apotex Description and Business Overview
    Table 71. Apotex Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 72. Apotex Glycopyrrolate Injection Product
    Table 73. Apotex Recent Developments/Updates
    Table 74. BE Pharmaceuticals Corporation Information
    Table 75. BE Pharmaceuticals Description and Business Overview
    Table 76. BE Pharmaceuticals Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 77. BE Pharmaceuticals Glycopyrrolate Injection Product
    Table 78. BE Pharmaceuticals Recent Developments/Updates
    Table 79. BluePoint Laboratories Corporation Information
    Table 80. BluePoint Laboratories Description and Business Overview
    Table 81. BluePoint Laboratories Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 82. BluePoint Laboratories Glycopyrrolate Injection Product
    Table 83. BluePoint Laboratories Recent Developments/Updates
    Table 84. Caplin Steriles Corporation Information
    Table 85. Caplin Steriles Description and Business Overview
    Table 86. Caplin Steriles Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 87. Caplin Steriles Glycopyrrolate Injection Product
    Table 88. Caplin Steriles Recent Developments/Updates
    Table 89. Civica Corporation Information
    Table 90. Civica Description and Business Overview
    Table 91. Civica Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 92. Civica Glycopyrrolate Injection Product
    Table 93. Civica Recent Developments/Updates
    Table 94. Fresenius Kabi Corporation Information
    Table 95. Fresenius Kabi Description and Business Overview
    Table 96. Fresenius Kabi Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 97. Fresenius Kabi Glycopyrrolate Injection Product
    Table 98. Fresenius Kabi Recent Developments/Updates
    Table 99. Gland Pharma Corporation Information
    Table 100. Gland Pharma Description and Business Overview
    Table 101. Gland Pharma Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 102. Gland Pharma Glycopyrrolate Injection Product
    Table 103. Gland Pharma Recent Developments/Updates
    Table 104. Hikma Corporation Information
    Table 105. Hikma Description and Business Overview
    Table 106. Hikma Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 107. Hikma Glycopyrrolate Injection Product
    Table 108. Hikma Recent Developments/Updates
    Table 109. Khandelwal Laboratories Corporation Information
    Table 110. Khandelwal Laboratories Description and Business Overview
    Table 111. Khandelwal Laboratories Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 112. Khandelwal Laboratories Glycopyrrolate Injection Product
    Table 113. Khandelwal Laboratories Recent Developments/Updates
    Table 114. Meitheal Corporation Information
    Table 115. Meitheal Description and Business Overview
    Table 116. Meitheal Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 117. Meitheal Glycopyrrolate Injection Product
    Table 118. Meitheal Recent Developments/Updates
    Table 119. Nivagen Pharmaceuticals Corporation Information
    Table 120. Nivagen Pharmaceuticals Description and Business Overview
    Table 121. Nivagen Pharmaceuticals Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 122. Nivagen Pharmaceuticals Glycopyrrolate Injection Product
    Table 123. Nivagen Pharmaceuticals Recent Developments/Updates
    Table 124. NorthStar Rx Corporation Information
    Table 125. NorthStar Rx Description and Business Overview
    Table 126. NorthStar Rx Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 127. NorthStar Rx Glycopyrrolate Injection Product
    Table 128. NorthStar Rx Recent Developments/Updates
    Table 129. Sandoz Corporation Information
    Table 130. Sandoz Description and Business Overview
    Table 131. Sandoz Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 132. Sandoz Glycopyrrolate Injection Product
    Table 133. Sandoz Recent Developments/Updates
    Table 134. Solco Healthcare Corporation Information
    Table 135. Solco Healthcare Description and Business Overview
    Table 136. Solco Healthcare Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 137. Solco Healthcare Glycopyrrolate Injection Product
    Table 138. Solco Healthcare Recent Developments/Updates
    Table 139. SteriMax Corporation Information
    Table 140. SteriMax Description and Business Overview
    Table 141. SteriMax Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 142. SteriMax Glycopyrrolate Injection Product
    Table 143. SteriMax Recent Developments/Updates
    Table 144. Xiromed Corporation Information
    Table 145. Xiromed Description and Business Overview
    Table 146. Xiromed Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 147. Xiromed Glycopyrrolate Injection Product
    Table 148. Xiromed Recent Developments/Updates
    Table 149. AuroMedics Pharma Corporation Information
    Table 150. AuroMedics Pharma Description and Business Overview
    Table 151. AuroMedics Pharma Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 152. AuroMedics Pharma Glycopyrrolate Injection Product
    Table 153. AuroMedics Pharma Recent Developments/Updates
    Table 154. Par Pharmaceutical Corporation Information
    Table 155. Par Pharmaceutical Description and Business Overview
    Table 156. Par Pharmaceutical Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 157. Par Pharmaceutical Glycopyrrolate Injection Product
    Table 158. Par Pharmaceutical Recent Developments/Updates
    Table 159. Piramal Critical Care Corporation Information
    Table 160. Piramal Critical Care Description and Business Overview
    Table 161. Piramal Critical Care Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 162. Piramal Critical Care Glycopyrrolate Injection Product
    Table 163. Piramal Critical Care Recent Developments/Updates
    Table 164. Somerset Therapeutics Corporation Information
    Table 165. Somerset Therapeutics Description and Business Overview
    Table 166. Somerset Therapeutics Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 167. Somerset Therapeutics Glycopyrrolate Injection Product
    Table 168. Somerset Therapeutics Recent Developments/Updates
    Table 169. West-ward Pharmaceutical Corporation Information
    Table 170. West-ward Pharmaceutical Description and Business Overview
    Table 171. West-ward Pharmaceutical Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 172. West-ward Pharmaceutical Glycopyrrolate Injection Product
    Table 173. West-ward Pharmaceutical Recent Developments/Updates
    Table 174. Zydus Pharmaceuticals Corporation Information
    Table 175. Zydus Pharmaceuticals Description and Business Overview
    Table 176. Zydus Pharmaceuticals Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 177. Zydus Pharmaceuticals Glycopyrrolate Injection Product
    Table 178. Zydus Pharmaceuticals Recent Developments/Updates
    Table 179. Hengrui Pharmaceuticals Corporation Information
    Table 180. Hengrui Pharmaceuticals Description and Business Overview
    Table 181. Hengrui Pharmaceuticals Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 182. Hengrui Pharmaceuticals Glycopyrrolate Injection Product
    Table 183. Hengrui Pharmaceuticals Recent Developments/Updates
    Table 184. Jiabo Pharmaceutical Corporation Information
    Table 185. Jiabo Pharmaceutical Description and Business Overview
    Table 186. Jiabo Pharmaceutical Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 187. Jiabo Pharmaceutical Glycopyrrolate Injection Product
    Table 188. Jiabo Pharmaceutical Recent Developments/Updates
    Table 189. Easton Biopharmaceuticals Corporation Information
    Table 190. Easton Biopharmaceuticals Description and Business Overview
    Table 191. Easton Biopharmaceuticals Glycopyrrolate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 192. Easton Biopharmaceuticals Glycopyrrolate Injection Product
    Table 193. Easton Biopharmaceuticals Recent Developments/Updates
    Table 194. Production Base and Market Concentration Rate of Raw Material
    Table 195. Key Suppliers of Raw Materials
    Table 196. Glycopyrrolate Injection Distributors List
    Table 197. Glycopyrrolate Injection Customers List
    Table 198. Glycopyrrolate Injection Market Trends
    Table 199. Glycopyrrolate Injection Market Drivers
    Table 200. Glycopyrrolate Injection Market Challenges
    Table 201. Glycopyrrolate Injection Market Restraints
    Table 202. Global Glycopyrrolate Injection Sales Forecast by Type (2023-2028) & (K Units)
    Table 203. Global Glycopyrrolate Injection Sales Market Share Forecast by Type (2023-2028)
    Table 204. Global Glycopyrrolate Injection Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 205. Global Glycopyrrolate Injection Revenue Market Share Forecast by Type (2023-2028)
    Table 206. Global Glycopyrrolate Injection Sales Forecast by Application (2023-2028) & (K Units)
    Table 207. Global Glycopyrrolate Injection Sales Market Share Forecast by Application (2023-2028)
    Table 208. Global Glycopyrrolate Injection Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 209. Global Glycopyrrolate Injection Revenue Market Share Forecast by Application (2023-2028)
    Table 210. Global Glycopyrrolate Injection Sales Forecast by Region (2023-2028) & (K Units)
    Table 211. Global Glycopyrrolate Injection Sales Market Share Forecast by Region (2023-2028)
    Table 212. Global Glycopyrrolate Injection Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 213. Global Glycopyrrolate Injection Revenue Market Share Forecast by Region (2023-2028)
    Table 214. Research Programs/Design for This Report
    Table 215. Key Data Information from Secondary Sources
    Table 216. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Glycopyrrolate Injection
    Figure 2. Global Glycopyrrolate Injection Market Share by Type in 2021 & 2028
    Figure 3. 0.2mg/ml Product Picture
    Figure 4. 0.4mg/2ml Product Picture
    Figure 5. 1mg/5ml Product Picture
    Figure 6. 4mg/20ml Product Picture
    Figure 7. Global Glycopyrrolate Injection Market Share by Application in 2021 & 2028
    Figure 8. Hospitals
    Figure 9. Clinics
    Figure 10. Others
    Figure 11. Global Glycopyrrolate Injection Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Glycopyrrolate Injection Market Size (2017-2028) & (US$ Million)
    Figure 13. Global Glycopyrrolate Injection Sales (2017-2028) & (K Units)
    Figure 14. Glycopyrrolate Injection Sales Share by Manufacturers in 2021
    Figure 15. Global Glycopyrrolate Injection Revenue Share by Manufacturers in 2021
    Figure 16. The Global 5 and 10 Largest Glycopyrrolate Injection Players: Market Share by Revenue in 2021
    Figure 17. Glycopyrrolate Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 18. Global Glycopyrrolate Injection Sales Market Share by Region (2017-2022)
    Figure 19. Global Glycopyrrolate Injection Sales Market Share by Region in 2021
    Figure 20. Global Glycopyrrolate Injection Revenue Market Share by Region (2017-2022)
    Figure 21. Global Glycopyrrolate Injection Revenue Market Share by Region in 2021
    Figure 22. United States Glycopyrrolate Injection Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. Canada Glycopyrrolate Injection Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. Germany Glycopyrrolate Injection Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. France Glycopyrrolate Injection Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. U.K. Glycopyrrolate Injection Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Italy Glycopyrrolate Injection Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Russia Glycopyrrolate Injection Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. China Glycopyrrolate Injection Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. Japan Glycopyrrolate Injection Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. South Korea Glycopyrrolate Injection Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. India Glycopyrrolate Injection Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Australia Glycopyrrolate Injection Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. China Taiwan Glycopyrrolate Injection Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Indonesia Glycopyrrolate Injection Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Thailand Glycopyrrolate Injection Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Malaysia Glycopyrrolate Injection Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Mexico Glycopyrrolate Injection Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Brazil Glycopyrrolate Injection Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Argentina Glycopyrrolate Injection Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Colombia Glycopyrrolate Injection Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Turkey Glycopyrrolate Injection Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Saudi Arabia Glycopyrrolate Injection Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. UAE Glycopyrrolate Injection Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 45. Sales Market Share of Glycopyrrolate Injection by Type (2017-2022)
    Figure 46. Manufacturing Cost Structure of Glycopyrrolate Injection
    Figure 47. Manufacturing Process Analysis of Glycopyrrolate Injection
    Figure 48. Glycopyrrolate Injection Industrial Chain Analysis
    Figure 49. Channels of Distribution
    Figure 50. Distributors Profiles
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation
    Figure 53. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Accord Healthcare
Advanz Pharma
American Regent
Amneal Pharmaceuticals
Apotex
BE Pharmaceuticals
BluePoint Laboratories
Caplin Steriles
Civica
Fresenius Kabi
Gland Pharma
Hikma
Khandelwal Laboratories
Meitheal
Nivagen Pharmaceuticals
NorthStar Rx
Sandoz
Solco Healthcare
SteriMax
Xiromed
AuroMedics Pharma
Par Pharmaceutical
Piramal Critical Care
Somerset Therapeutics
West-ward Pharmaceutical
Zydus Pharmaceuticals
Hengrui Pharmaceuticals
Jiabo Pharmaceutical
Easton Biopharmaceuticals
Frequently Asked Questions
Glycopyrrolate Injection report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Glycopyrrolate Injection report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Glycopyrrolate Injection report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Acyclovir Ointment

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More

Vacuum Presses

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More

Vacuum Membranes

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More